Submit Deal

Announced

3 May 2022

Completed

3 May 2022

Sanofi completed the spin-off of EUROAPI at a €1.15bn valuation.

Synopsis

Sanofi, a French multinational pharmaceutical and healthcare company headquartered in Paris, completed the spin-off of EUROAPI, a pharmaceutical company, at a €1.15bn valuation.

Principals

target

EUROAPI

bidder

Institutional Investors

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (3)

aude lepreux

Account Director at Brunswick Group

PR Consultant

target

Deals

£ 880 M

Total Value

hugues boeton

Partner at Brunswick Group

PR Consultant

target

Deals

£ 6.30 B

Total Value

david seignolle

CEO at EUROAPI

Manager

target

Deal

£ 560 M

Total Value

Vendor Team (4)

gael saint olive

Partner at Jones Day

Lawyer

vendor

Deals

£ 560 M

Total Value

paul hudson

CEO at SANOFI SA

Manager

vendor

Deals

£ 29.40 B

Total Value

linda hesse

Partner at Jones Day

Lawyer

vendor

Deals

£ 11.85 B

Total Value

stefano beschi

Global Partner at Rothschild & Co

Financial Advisor

vendor

Deals

£ 22.68 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy